secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surgery Partners, Inc. (SGRY)
CIK:        0001638833
Form:       8-K
Filed at:   2025-08-05T23:59:59+00:00
Accession:  0001638833-25-000132
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surgery Partners Q2 revenue up 8.4% to $826.2M; Adj EBITDA $129M, up 9%; reaffirms FY2025 guidance
--------------------------------------------------------------------------------

- Revenue $826.2M (+8.4% YoY); same-facility revenue +5.1%, same-facility cases +3.4%.
- Adjusted EBITDA $129.0M (+9.0% YoY); net loss attributable to Surgery Partners $2.5M.
- Full-year 2025 guidance reaffirmed: revenue $3.30-3.45B, Adjusted EBITDA $555-565M.
- Cash $250.1M and $394.9M revolver capacity at June 30, 2025; net debt/EBITDA 4.1x.
- CEO cites active evaluation of portfolio optimization to reduce leverage and accelerate cash flow.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638833/000163883325000132/0001638833-25-000132-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638833/000163883325000132/sgry-20250805.htm
  HTML page:      https://secwatch.observer/filing/0001638833-25-000132

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer